SJD Barcelona Children’s Hospital
SJD Barcelona Children’s Hospital
Espanha, Barcelona
Hanya untuk anak-anak & remaja (0-18)
Jaume Mora Graupera
30 tahun pengalaman
akreditasi :
Klinik telah bersertifikat :
| Turki | Austria | Espanha | |
| Terapi radiasi untuk kanker kolorektal | dari $7,000 | dari $12,000 | dari $10,000 |
| Radiosurgery stereotaktik | dari $4,500 | dari $17,000 | dari $12,000 |
| Pisau Gamma | dari $6,300 | dari $32,000 | dari $18,000 |
| Kraniotomi | dari $5,650 | dari $20,000 | dari $25,000 |
| Kemoterapi untuk kanker payudara | dari $1,200 | dari $15,000 | dari $3,500 |
Dr. Javier Herrero Jover adalah pelopor dalam perencanaan bedah 3D, membawa lebih dari 30 tahun keahlian ke Centro Médico Teknon.
Dr. Bartolome Oliver adalah pelopor dalam bedah saraf invasif minimal, yang telah melakukan lebih dari 900 pengobatan tumor otak dengan teknik canggih.
Dr. Graupera mengembangkan terapi pasif untuk glioma sumsum tulang belakang tanpa terapi radiasi – sebuah terobosan dalam onkologi pediatrik. Kepala Departemen Hematologi Onkologi di Sant Joan De Déu.
Pelopor dalam menetapkan kriteria ketat untuk sindrom neurologis paraneoplastik – Dr. Graus adalah tokoh terkemuka dalam neuro-onkologi di Hospital Quiron Barcelona.
Patients choose Spain for glioma treatment to access advanced neuro-oncology protocols like fluorescence-guided surgery and Tumor Treating Fields. Spanish centers provide faster access to urgent interventions. JCI-accredited facilities in Barcelona and Madrid offer specialized care from neurosurgeons with over 40 years of experience.
Bookimed Expert Insight: Data shows Spain is a top destination for complex neurosurgery, ranking 3rd globally in our network. While many focus on surgery, the real value is in the integrated diagnostics. For example, packages at Hospital Ruber Internacional include PET-CT and angiography alongside surgery. This comprehensive approach often saves patients 7-10 days in the critical planning phase.
Patient Consensus: Patients note that avoiding long wait times for biopsies and imaging is a primary motivator. Many emphasize that the ability to secure online consultations within 24 hours provides vital peace of mind when facing urgent tumor progression.
Top-rated hospitals for glioma treatment in Spain include Centro Medico Teknon, Hospital Ruber Internacional, and Clinica Universidad de Navarra. These JCI-accredited centers specialize in fluorescence-guided resection. They utilize advanced technologies like Gamma Knife and TrueBeam to maximize tumor removal while preserving neurological function.
Bookimed Expert Insight: While hospital reputation is important, our data reveals that specialized neuro-oncology packages often include vital diagnostics like PET-CT and MRI. For instance, Hospital Ruber Internacional offers a $35,000 comprehensive Gamma Knife package, whereas Teknon provides targeted radiosurgery for $16,000. Choosing based on the specific neurosurgeon’s annual glioma volume often ensures better functional outcomes after complex resections.
Patient Consensus: Patients emphasize finding a hospital with a dedicated multidisciplinary tumor board. They note that quick response times for second opinions and fast MRI scheduling are essential for managing aggressive brain tumors.
Spain is a top European neuro-oncology hub. Facilities offer Gamma Knife radiosurgery, MR-Linac guided therapies, and awake craniotomies for gliomas. Specialized centers utilize fluorescence-guided surgery to maximize tumor resection. Patients can access innovative dendritic cell vaccines and genetic trials for glioblastoma treatment.
Bookimed Expert Insight: While standard treatments are widely available, the infrastructure in Spain allows for faster access to radiosurgery. For instance, Hospital Ruber Internacional and Centro Médico Teknon report high volumes for Gamma Knife and Truebeam. This suggests centers prioritize non-invasive options for early-stage or deep-seated tumors. Patients often save time by coordinating diagnostics like PET-CT and MRI in 1-day bundles at these clinics.
Patient Consensus: Patients emphasize the value of getting a second opinion from major university hospitals. They note that having full molecular profiling for markers like IDH and MGMT is essential for qualifying for the latest targeted trials.